acebutolol has been researched along with cardiovascular agents in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Draganov, V; Manolov, P; Stankusheva, G | 1 |
| Chary, NS; Lin, AY; Lin, CA; Tung, HH | 1 |
| Cook, JC; Patterson, JH; Rodgers, JE; Tran, RH | 1 |
| Lam, CSP; Teramoto, K; Tromp, J | 1 |
1 review(s) available for acebutolol and cardiovascular agents
| Article | Year |
|---|---|
Evolving therapies for the management of chronic and acute decompensated heart failure.
Topics: Acute Disease; Adrenergic beta-Antagonists; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Biphenyl Compounds; Cardiovascular Agents; Chronic Disease; Clinical Trials as Topic; Disease Management; Drug Combinations; Ferric Compounds; Heart Failure; Humans; Ivabradine; Maltose; Tetrazoles; Valsartan | 2016 |
3 other study(ies) available for acebutolol and cardiovascular agents
| Article | Year |
|---|---|
[Hemodynamic changes during treatment with isodinit, sectral, stenopril and kratemon].
Topics: Acebutolol; Adult; Aged; Cardiovascular Agents; Coronary Disease; Delayed-Action Preparations; Drug Evaluation; Female; Flavonoids; Hemodynamics; Humans; Hypertension; Isosorbide Dinitrate; Male; Middle Aged; Phenethylamines; Tablets; Time Factors | 1987 |
Potential for biodegradation and sorption of acetaminophen, caffeine, propranolol and acebutolol in lab-scale aqueous environments.
Topics: Acebutolol; Acetaminophen; Adsorption; Biodegradation, Environmental; Caffeine; Cardiovascular Agents; Central Nervous System Stimulants; Clinical Laboratory Techniques; Environmental Restoration and Remediation; Propranolol; Sensory System Agents; Water Pollutants, Chemical | 2010 |
Heart failure or heart success?
Topics: Cardiovascular Agents; Evidence-Based Medicine; Ferric Compounds; Glycosides; Heart Failure, Systolic; Hospitalization; Humans; Maltose; Randomized Controlled Trials as Topic; Recovery of Function; Research Design; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2 Inhibitors; Stroke Volume; Treatment Outcome; Urea; Ventricular Function, Left | 2021 |